Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system

Int J Radiat Oncol Biol Phys. 1990 Aug;19(2):265-74. doi: 10.1016/0360-3016(90)90533-p.


Seventy-two children with posterior fossa medulloblastoma were diagnosed at the Hospital for Sick Children, Toronto, from 1977 to 1987 and treated by standard methods. The 5- and 10-year survival and disease-free survival rates were 71% and 63%, and 64% and 63%, respectively. Total tumor resection, as determined by the surgeon was the most significant favorable prognostic factor. Post-operative meningitis, a residual enhancing mass lesion on the post-operative, pre irradiation CT scan and dissemination to the brain or cord at diagnosis were unfavorable factors. These four easily definable factors were used to define a staging system with prognostic significance. Five-year disease-free survival rates were for Stage I (total resection, no adverse factor) 100%, Stage II (total resection with one or more adverse factor or less than total resection with no other adverse factor) 78%, and Stage III (less than total resection with one or more adverse factor) 18%. Evaluation of treatment results in medulloblastoma requires that these prognostic factors be known.

MeSH terms

  • Adolescent
  • Cerebellar Neoplasms / epidemiology
  • Cerebellar Neoplasms / mortality
  • Cerebellar Neoplasms / therapy*
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Cranial Fossa, Posterior
  • Female
  • Humans
  • Infant
  • Male
  • Medulloblastoma / epidemiology
  • Medulloblastoma / mortality
  • Medulloblastoma / therapy*
  • Neoplasm Staging*
  • Ontario / epidemiology
  • Regression Analysis
  • Retrospective Studies
  • Survival Analysis
  • Survival Rate